Pulmonary Arterial Hypertension

Pulmonary arterial hypertension refers to the high blood pressure in the arteries that go from the heart ot the lungs. Here is the latest research.

July 6, 2020

Rapid transition from oral selexipag to parenteral treprostinil in a patient with mixed-etiology pulmonary hypertension

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
John J RadosevichJeremy Feldman
July 1, 2020

Evolution of pathogenetic therapy of pulmonary arterial hypertension

Terapevticheskiĭ arkhiv
I E ChazovaN M Danilov
July 9, 2020
Open Access

Pulmonary Arterial Hypertension and Sex in the Right Ventricle - It is an Interesting Picture!

American Journal of Respiratory and Critical Care Medicine
Thenappan Thenappan, E Kenneth Weir
June 27, 2020
Open Access

Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival

Scandinavian Cardiovascular Journal : SCJ
Anna SandqvistStefan Söderberg
July 3, 2020

Endothelin-1 Induces Lysyl Oxidase Expression in Pulmonary Artery Smooth Muscle Cells

Canadian Journal of Physiology and Pharmacology
Hidekazu MaruyamaMasaki Ieda
July 8, 2020
Open Access

Protective effect of nicotinamide and L-arginine against monocrotaline-induced pulmonary hypertension in rats: gender dependence

Pharmacological Reports : PR
Katarzyna Sztormowska-AchranowiczIvan Kocić

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved